National Research Stock Price, News & Analysis (NASDAQ:NRCI)

$60.10 0.00 (0.00 %)
(As of 11/18/2017 09:26 AM ET)
Previous Close$60.10
Today's RangeN/A
52-Week Range$41.00 - $64.36
VolumeN/A
Average Volume14,833 shs
Market Capitalization$1.45 billion
P/E RatioN/A
Dividend Yield4.13%
Beta0.83

About National Research (NASDAQ:NRCI)

National Research logoNational Research Corporation (NRC) is a provider of analytics and insights that facilitate revenue growth, patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. The Company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The Company's clients range from acute care hospitals and post-acute providers, such as home health, long term care and hospice, to numerous payer organizations. The Company derives its revenue from its annually renewable services, which include performance measurement and improvement services, healthcare analytics and governance education services.


Industry, Sector and Symbol:
  • Industry: Business Support Services
  • Sub-Industry: N/A
  • Sector: Business Support Services - NEC
  • Symbol: NASDAQ:NRCI
  • CUSIP: N/A
  • Web: nrchealth.com
Dividend:
  • Dividend Yield: 4.1%
Misc:
     

    Frequently Asked Questions for National Research (NASDAQ:NRCI)

    What is National Research's stock symbol?

    National Research trades on the NASDAQ under the ticker symbol "NRCI."

    Where is National Research's stock going? Where will National Research's stock price be in 2017?

    1 brokerages have issued 12 month target prices for National Research's stock. Their forecasts range from $44.00 to $44.00. On average, they expect National Research's stock price to reach $44.00 in the next year. View Analyst Ratings for National Research.

    Who are some of National Research's key competitors?

    Who are National Research's key executives?

    National Research's management team includes the folowing people:

    • Steven D. Jackson, President (Age 41)
    • Michael D. Hays, Chief Executive Officer, Director (Age 62)
    • Kevin R. Karas, Chief Financial Officer, Senior Vice President - Finance, Treasurer, Secretary (Age 59)
    • John N. Nunnelly, Lead Independent Director (Age 64)
    • Donald M. Berwick M.D., Independent Director (Age 70)
    • JoAnn M. Martin, Independent Director (Age 62)
    • Barbara J Mowry, Independent Director (Age 69)

    How do I buy National Research stock?

    Shares of National Research can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is National Research's stock price today?

    One share of National Research stock can currently be purchased for approximately $60.10.

    How big of a company is National Research?

    National Research has a market capitalization of $1.45 billion.

    How can I contact National Research?

    National Research's mailing address is 1245 Q St, LINCOLN, NE 68508-1430, United States. The company can be reached via phone at +1-402-4752525.


    MarketBeat Community Rating for National Research (NASDAQ NRCI)

    Community Ranking:  2.3 out of 5 (star star)
    Outperform Votes:  34 (Vote Outperform)
    Underperform Votes:  40 (Vote Underperform)
    Total Votes:  74
    MarketBeat's community ratings are surveys of what our community members think about National Research and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Analysts' Consensus Rating for National Research (NASDAQ:NRCI)

      (How are Consensus Ratings Calculated?)
    Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 0 Buy Ratings, 0 Strong Buy Ratings
    Consensus Rating:Hold (Score: 2.00)
    Consensus Price Target: $44.00 (26.79% downside)

    Consensus Price Target History for National Research (NASDAQ:NRCI)

    Price Target History for National Research (NASDAQ:NRCI)

    Analysts' Ratings History for National Research (NASDAQ:NRCI)

    Show:
    DateFirmActionRatingPrice TargetImpact on Share PriceDetails
    2/16/2017First AnalysisReiterated RatingOverweight -> Equal Weight$45.00 -> $44.00N/AView Rating Details
    (Data available from 11/19/2015 forward)

    Earnings

    Earnings History and Estimates Chart for National Research (NASDAQ:NRCI)

    Earnings by Quarter for National Research (NASDAQ:NRCI)

    Earnings History by Quarter for National Research (NASDAQ NRCI)

    DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
    11/6/2012Q312$0.47$0.51$21.52 million$21.40 millionViewN/AView Earnings Details
    (Data available from 1/1/2011 forward)

    Estimates

    Earnings Estimates for National Research (NASDAQ:NRCI)

    No earnings estimates for this company have been tracked by MarketBeat.com

    Dividends

    Dividend History by Quarter for National Research (NASDAQ NRCI)

    AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
    2/6/2013quarterly$0.312.29%2/14/20132/19/20133/29/2013
    (Data available from 1/1/2013 forward)

    Insider Trades

    Insider Trading History for National Research (NASDAQ NRCI)
    No insider trades for this company have been tracked by MarketBeat.com

    Headlines

    Latest Headlines for National Research (NASDAQ NRCI)

    Source:
    No headlines for this company have been tracked by MarketBeat.com

    Social Media

    Financials

    Financials are not available for this stock.

    Chart

    National Research (NASDAQ NRCI) Chart for Sunday, November, 19, 2017
    Loading chart…

    This page was last updated on 11/19/2017 by MarketBeat.com Staff

    Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.